LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2013

Feb 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2013-02-08

Reporting Person: MAIN ALAN J (EVP, Pharmaceutical Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-08	Restricted Stock Units (Phantom Stock)	$	A	66000	Acquired		Common Stock (66000)	Direct
2013-02-08	Stock Option (Right to Buy)	$2.09	A	264000	Acquired	2023-02-08	Common Stock (264000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years

F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2014) and vests 1/48th per month for each month of service thereafter